Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 23;34(8):1017-1022.
doi: 10.1515/jpem-2021-0303. Print 2021 Aug 26.

Molecular and clinical findings of Turkish patients with hereditary fructose intolerance

Mehmet Gunduz  1 , Özlem Ünal-Uzun  2 , Nevra Koç  3 , Serdar Ceylaner  4 , Eda Özaydın  5 , Çiğdem Seher Kasapkara  6
Affiliations

Molecular and clinical findings of Turkish patients with hereditary fructose intolerance

Mehmet Gunduz et al. J Pediatr Endocrinol Metab. .

Abstract

Objectives: Hereditary fructose intolerance (HFI) is an autosomal recessive disorder caused by a deficiency in aldolase B that can result in hypoglycemia, nausea, vomiting, abdominal pain, liver and kidney dysfunction, coma, and even death. This study aims to represent the clinical features and molecular genetic analysis data of the patients diagnosed with HFI in our study population.

Methods: The medical records of the 26 patients with HFI were evaluated retrospectively. Age, gender, clinical findings, metabolic crises, and the results of molecular analyses were recorded.

Results: The patients with HFI had a good prognosis and the aversion to sugar-containing foods was the main complaint. Seven different variants were identified in the Aldolase B (ALDOB) gene in HFI patients. The most frequent mutations were p.Ala150Pro, p.Ala175Asp had a prevalence of 61 and 30%, respectively, in agreement with the literature and other known variants were found with minor frequencies c.360-363del4(3.8%), p.Asn335Lys(3.8%), and three novel mutations c.113-1_15del4 (3.8%), p.Ala338Val(7.6%), and p.Asp156His(3.8%) were identified at a heterozygous, homozygous, or compound heterozygous level.

Conclusions: This study results revealed three novel mutations in patients with HFI. On the basis of age of presentation, clinical symptoms, and metabolic crisis, there was no clear-cut genotype-phenotype correlation. This article also demonstrates the importance of screening suspected infants in cases of acute liver failure for prompt diagnosis and treatment of HFI.

Keywords: aversion to sugar; hereditary fructose intolerance; molecular characteristics.

PubMed Disclaimer

References

    1. Steinman, B, Santer, R. Disorders of fructose metabolism. In: Saudubray, JM, van den Berghe, G, Walter, JH, editors Inborn metabolic diseases, 5th ed. Heidelberg: Springer-Verlag Berlin; 2011.
    1. Rake, JP, Visser, G, Smit, GPA. Disorders of carbohydrate and glycogen metabolism. In: Blau, N, Hoffmann, GF, Leonard, J, Clarke, JTR, editors. Physician’s guide to the treatment and follow-up of metabolic diseases. Heidelberg: Springer; 2006.
    1. Mayatepek, E, Hoffmann, B, Meissner, T. Inborn errors of carbohydrate metabolism. Best Pract Res Clin Gastroenterol 2010;24:607–18. https://doi.org/10.1016/j.bpg.2010.07.012.
    1. Steinmann, B, Gitzelmann, R, Van den Berghe, G. Disorders of fructose metabolism. In: Scriver, CR, Beaudet, AL, Sly, WS, Valle, D, editors. The metabolic and molecular bases of inherited disease, 8th ed. New York: McGraw-Hill; 2001:1489–520 pp.
    1. Tolan, DR. Molecular basis of hereditary fructose intolerance:mutations and polymorphisms in the human aldolase B gene. Hum Mutat 1995;6:210–18. https://doi.org/10.1002/humu.1380060303.

MeSH terms

Substances